annual net income:
-$73.88M-$25.15M(-51.63%)Summary
- As of today (August 16, 2025), AMRX annual net profit is -$73.88 million, with the most recent change of -$25.15 million (-51.63%) on December 31, 2024.
- During the last 3 years, AMRX annual net income has fallen by -$94.05 million (-466.27%).
- AMRX annual net income is now -129.51% below its all-time high of $250.36 million, reached on December 1, 2010.
Performance
AMRX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$35.61M+$10.99M(+44.65%)Summary
- As of today (August 16, 2025), AMRX quarterly net profit is $35.61 million, with the most recent change of +$10.99 million (+44.65%) on June 30, 2025.
- Over the past year, AMRX quarterly net income has increased by +$18.82 million (+112.13%).
- AMRX quarterly net income is now -72.91% below its all-time high of $131.46 million, reached on March 1, 2010.
Performance
AMRX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$51.24M+$18.82M(+58.06%)Summary
- As of today (August 16, 2025), AMRX TTM net profit is $51.24 million, with the most recent change of +$18.82 million (+58.06%) on June 30, 2025.
- Over the past year, AMRX TTM net income has increased by +$184.44 million (+138.47%).
- AMRX TTM net income is now -81.44% below its all-time high of $276.13 million, reached on September 1, 2010.
Performance
AMRX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
AMRX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.6% | +112.1% | +138.5% |
| 3 y3 years | -466.3% | +114.8% | +118.8% |
| 5 y5 years | +87.8% | +248.7% | +115.5% |
AMRX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -466.3% | +71.0% | at high | +114.8% | at high | +118.8% |
| 5 y | 5-year | -207.7% | +87.8% | at high | +114.8% | -25.3% | +115.5% |
| alltime | all time | -129.5% | +87.8% | -72.9% | +109.8% | -81.4% | +108.5% |
AMRX Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $35.61M(+44.7%) | $51.24M(+58.1%) |
| Mar 2025 | - | $24.62M(-218.7%) | $32.42M(-143.9%) |
| Dec 2024 | -$73.88M(+51.6%) | -$20.74M(-276.4%) | -$73.88M(-49.6%) |
| Sep 2024 | - | $11.76M(-30.0%) | -$146.48M(+10.0%) |
| Jun 2024 | - | $16.79M(-120.6%) | -$133.20M(+10.7%) |
| Mar 2024 | - | -$81.68M(-12.5%) | -$120.31M(+146.9%) |
| Dec 2023 | -$48.72M(-80.9%) | -$93.34M(-472.9%) | -$48.72M(-225.7%) |
| Sep 2023 | - | $25.03M(-15.7%) | $38.76M(+241.8%) |
| Jun 2023 | - | $29.68M(-394.1%) | $11.34M(-104.4%) |
| Mar 2023 | - | -$10.09M(+72.3%) | -$258.42M(+1.4%) |
| Dec 2022 | -$254.79M(-1363.2%) | -$5.86M(+145.1%) | -$254.79M(-5.4%) |
| Sep 2022 | - | -$2.39M(-99.0%) | -$269.39M(-1.4%) |
| Jun 2022 | - | -$240.08M(+3616.4%) | -$273.09M(>+9900.0%) |
| Mar 2022 | - | -$6.46M(-68.4%) | -$835.00K(-104.1%) |
| Dec 2021 | $20.17M(-70.6%) | -$20.46M(+235.8%) | $20.17M(-40.1%) |
| Sep 2021 | - | -$6.09M(-118.9%) | $33.67M(+89.9%) |
| Jun 2021 | - | $32.18M(+121.2%) | $17.73M(-146.2%) |
| Mar 2021 | - | $14.54M(-308.9%) | -$38.39M(-156.0%) |
| Dec 2020 | $68.58M(-111.4%) | -$6.96M(-68.4%) | $68.58M(+544.7%) |
| Sep 2020 | - | -$22.03M(-8.0%) | $10.64M(-103.2%) |
| Jun 2020 | - | -$23.94M(-119.7%) | -$330.72M(-7.4%) |
| Mar 2020 | - | $121.52M(-287.2%) | -$357.30M(-40.8%) |
| Dec 2019 | -$603.57M(+1049.7%) | -$64.90M(-82.1%) | -$603.57M(+8.0%) |
| Sep 2019 | - | -$363.39M(+619.2%) | -$559.00M(+213.8%) |
| Jun 2019 | - | -$50.53M(-59.5%) | -$178.14M(+0.4%) |
| Mar 2019 | - | -$124.75M(+513.6%) | -$177.37M(+237.9%) |
| Dec 2018 | -$52.50M(-3230.4%) | -$20.33M(-216.4%) | -$52.50M(+66.4%) |
| Sep 2018 | - | $17.46M(-135.1%) | -$31.54M(-35.2%) |
| Jun 2018 | - | -$49.75M(<-9900.0%) | -$48.66M(-3611.2%) |
| Mar 2018 | - | $117.00K(-81.3%) | $1.39M(+9.2%) |
| Dec 2017 | $1.68M(-100.4%) | $625.00K(+82.7%) | $1.27M(-100.5%) |
| Sep 2017 | - | $342.00K(+13.2%) | -$278.94M(-39.2%) |
| Jun 2017 | - | $302.00K(>+9900.0%) | -$458.62M(-0.7%) |
| Mar 2017 | - | $0.00(-100.0%) | -$461.62M(-2.2%) |
| Dec 2016 | -$472.03M(-1310.4%) | - | - |
| Dec 2016 | - | -$279.58M(+55.9%) | -$472.03M(+160.8%) |
| Sep 2016 | - | -$179.34M(+6539.7%) | -$181.02M(-631.3%) |
| Jun 2016 | - | -$2.70M(-74.0%) | $34.07M(-2.4%) |
| Mar 2016 | - | -$10.41M(-191.1%) | $34.92M(-10.4%) |
| Dec 2015 | $39.00M(-32.0%) | $11.43M(-68.0%) | $39.00M(+40.8%) |
| Sep 2015 | - | $35.76M(-2030.6%) | $27.69M(+260.9%) |
| Jun 2015 | - | -$1.85M(-70.8%) | $7.67M(-82.8%) |
| Mar 2015 | - | -$6.33M(-5377.5%) | $44.59M(-22.2%) |
| Dec 2014 | $57.35M(-43.4%) | $120.00K(-99.2%) | $57.35M(+20.5%) |
| Sep 2014 | - | $15.74M(-55.1%) | $47.61M(+50.2%) |
| Jun 2014 | - | $35.07M(+445.9%) | $31.69M(+1313.6%) |
| Mar 2014 | - | $6.42M(-166.8%) | $2.24M(-97.8%) |
| Dec 2013 | $101.26M(+81.2%) | -$9.62M(+5245.6%) | $101.26M(-12.5%) |
| Sep 2013 | - | -$180.00K(-103.2%) | $115.79M(-14.8%) |
| Jun 2013 | - | $5.62M(-94.7%) | $135.97M(-8.7%) |
| Mar 2013 | - | $105.44M(+2047.9%) | $148.98M(+166.6%) |
| Dec 2012 | $55.87M | $4.91M(-75.5%) | $55.87M(-23.2%) |
| Sep 2012 | - | $20.00M(+7.3%) | $72.80M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $18.63M(+51.1%) | $69.98M(+9.6%) |
| Mar 2012 | - | $12.33M(-43.5%) | $63.87M(-2.3%) |
| Dec 2011 | $65.40M(-73.9%) | $21.83M(+27.1%) | $65.40M(+16.8%) |
| Sep 2011 | - | $17.18M(+37.2%) | $55.97M(-50.9%) |
| Jun 2011 | - | $12.53M(-9.6%) | $113.92M(-14.2%) |
| Mar 2011 | - | $13.86M(+11.7%) | $132.70M(-47.0%) |
| Dec 2010 | $250.36M(+401.0%) | $12.40M(-83.5%) | $250.30M(-9.4%) |
| Sep 2010 | - | $75.14M(+140.0%) | $276.13M(+33.0%) |
| Jun 2010 | - | $31.31M(-76.2%) | $207.68M(+15.8%) |
| Mar 2010 | - | $131.46M(+243.8%) | $179.39M(+257.7%) |
| Dec 2009 | $49.97M(+167.2%) | $38.23M(+471.9%) | $50.15M(+139.1%) |
| Sep 2009 | - | $6.68M(+121.9%) | $20.98M(+290.2%) |
| Jun 2009 | - | $3.01M(+35.8%) | $5.38M(-73.1%) |
| Mar 2009 | - | $2.22M(-75.5%) | $19.96M(+6.7%) |
| Dec 2008 | $18.70M(-85.1%) | $9.06M(-201.6%) | $18.70M(+15.8%) |
| Sep 2008 | - | -$8.91M(-150.7%) | $16.14M(-76.4%) |
| Jun 2008 | - | $17.60M(+1732.9%) | $68.46M(-49.2%) |
| Mar 2008 | - | $960.00K(-85.2%) | $134.65M(+6.9%) |
| Dec 2007 | $125.92M(-1145.5%) | $6.50M(-85.0%) | $125.92M(-3.7%) |
| Sep 2007 | - | $43.40M(-48.2%) | $130.83M(+55.4%) |
| Jun 2007 | - | $83.79M(-1178.5%) | $84.17M(-1000.6%) |
| Mar 2007 | - | -$7.77M(-168.1%) | -$9.35M(-22.4%) |
| Dec 2006 | -$12.04M(+108.4%) | $11.40M(-449.8%) | -$12.04M(-48.6%) |
| Sep 2006 | - | -$3.26M(-66.5%) | -$23.45M(+16.1%) |
| Jun 2006 | - | -$9.72M(-7.1%) | -$20.19M(+92.9%) |
| Mar 2006 | - | -$10.47M(-1524.1%) | -$10.47M(-994.6%) |
| Dec 2005 | -$5.78M(-59.3%) | - | - |
| Sep 2004 | - | $735.00K(+129.0%) | $1.17M(-136.9%) |
| Jun 2004 | - | $321.00K(-93.8%) | -$3.17M(-45.1%) |
| Mar 2004 | - | $5.22M(-202.2%) | -$5.78M(-59.3%) |
| Dec 2003 | -$14.21M(-29.1%) | -$5.10M(+41.4%) | -$14.21M(+13.0%) |
| Sep 2003 | - | -$3.61M(+58.0%) | -$12.58M(-11.3%) |
| Jun 2003 | - | -$2.28M(-28.9%) | -$14.18M(-20.5%) |
| Mar 2003 | - | -$3.21M(-7.4%) | -$17.83M(-11.0%) |
| Dec 2002 | -$20.04M(-20.2%) | -$3.47M(-33.4%) | -$20.04M(-14.4%) |
| Sep 2002 | - | -$5.21M(-12.3%) | -$23.42M(-6.2%) |
| Jun 2002 | - | -$5.94M(+9.5%) | -$24.98M(-0.8%) |
| Mar 2002 | - | -$5.42M(-20.9%) | -$25.19M(+0.3%) |
| Dec 2001 | -$25.11M(+1.8%) | -$6.85M(+1.3%) | -$25.11M(+4.4%) |
| Sep 2001 | - | -$6.77M(+10.1%) | -$24.06M(-10.6%) |
| Jun 2001 | - | -$6.15M(+15.2%) | -$26.91M(+3.9%) |
| Mar 2001 | - | -$5.34M(-8.0%) | -$25.91M(+3.8%) |
| Dec 2000 | -$24.67M(+175.7%) | -$5.80M(-39.7%) | -$24.96M(+30.3%) |
| Sep 2000 | - | -$9.62M(+86.9%) | -$19.16M(+94.8%) |
| Jun 2000 | - | -$5.15M(+17.2%) | -$9.84M(+81.7%) |
| Mar 2000 | - | -$4.39M(<-9900.0%) | -$5.41M(+193.8%) |
| Dec 1999 | -$8.95M(+93.9%) | $0.00(-100.0%) | -$1.84M(-42.3%) |
| Sep 1999 | - | -$297.00K(-59.0%) | -$3.19M(-16.2%) |
| Jun 1999 | - | -$725.00K(-11.7%) | -$3.81M(-14.2%) |
| Mar 1999 | - | -$821.00K(-39.3%) | -$4.45M(-3.6%) |
| Dec 1998 | -$4.62M | -$1.35M(+47.6%) | -$4.62M(+41.4%) |
| Sep 1998 | - | -$916.00K(-32.5%) | -$3.26M(+39.0%) |
| Jun 1998 | - | -$1.36M(+37.3%) | -$2.35M(+137.3%) |
| Mar 1998 | - | -$989.00K | -$989.00K |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual net profit?
- What is the all time high annual net income for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual net income year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly net profit?
- What is the all time high quarterly net income for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM net profit?
- What is the all time high TTM net income for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM net income year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual net profit?
The current annual net income of AMRX is -$73.88M
What is the all time high annual net income for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual net profit is $250.36M
What is Amneal Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, AMRX annual net profit has changed by -$25.15M (-51.63%)
What is Amneal Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of AMRX is $35.61M
What is the all time high quarterly net income for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly net profit is $131.46M
What is Amneal Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, AMRX quarterly net profit has changed by +$18.82M (+112.13%)
What is Amneal Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of AMRX is $51.24M
What is the all time high TTM net income for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM net profit is $276.13M
What is Amneal Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, AMRX TTM net profit has changed by +$184.44M (+138.47%)